The steroid receptor RNA activator protein is expressed in breast tumor tissues - PubMed (original) (raw)
. 2006 Feb 15;118(4):1054-9.
doi: 10.1002/ijc.21425.
Affiliations
- PMID: 16152589
- DOI: 10.1002/ijc.21425
The steroid receptor RNA activator protein is expressed in breast tumor tissues
Shilpa Chooniedass-Kothari et al. Int J Cancer. 2006.
Abstract
The steroid receptor RNA activator (SRA) was originally described as the first functional noncoding RNA able to specifically coactivate the activity of steroid receptors. We previously demonstrated the existence in breast cancer cell lines of new SRA isoforms that, as opposed to the first cloned SRA RNA, encode for a 236-amino acid protein, SRAP. To investigate the possible implications of the coding SRA RNA and SRAP expression on breast cancer progression, we examined by Western blot analysis 74 primary breast tumors of patients subsequently treated with tamoxifen. Patients whose primary tumors were positive for SRAP expression (n = 24) had a significantly (Kaplan-Meier survival curve p = 0.047) lower likelihood of dying from recurrent disease than SRAP-negative patients (n = 50). We generated 2 cell lines, SRAP-V5-High.A and SRAP-V5-High.B, by stably overexpressing SRAP in the estrogen receptor-positive MCF-7 breast cancer cell line. Transient transfection experiments, performed using a luciferase reporter gene under the control of an estrogen-responsive element, revealed decreased sensitivity to estradiol but no additional sensitivity to tamoxifen in SRAP-overexpressing cells. Overall, our data suggest that the presence of both coding SRA RNA and its corresponding SRAP modifies the activity of estrogen receptor in breast cancer cells and that SRAP could be a new clinical marker for breast cancer. Further studies are needed to define the respective mechanisms of action and the roles of SRA RNA and protein in breast tumorigenesis and tumor progression.
Similar articles
- Steroid Receptor RNA Activator Protein (SRAP): a potential new prognostic marker for estrogen receptor-positive/node-negative/younger breast cancer patients.
Yan Y, Skliris GP, Penner C, Chooniedass-Kothari S, Cooper C, Nugent Z, Blanchard A, Watson PH, Myal Y, Murphy LC, Leygue E. Yan Y, et al. Breast Cancer Res. 2009;11(5):R67. doi: 10.1186/bcr2359. Breast Cancer Res. 2009. PMID: 19740422 Free PMC article. - Alternative splicing of the first intron of the steroid receptor RNA activator (SRA) participates in the generation of coding and noncoding RNA isoforms in breast cancer cell lines.
Hube F, Guo J, Chooniedass-Kothari S, Cooper C, Hamedani MK, Dibrov AA, Blanchard AA, Wang X, Deng G, Myal Y, Leygue E. Hube F, et al. DNA Cell Biol. 2006 Jul;25(7):418-28. doi: 10.1089/dna.2006.25.418. DNA Cell Biol. 2006. PMID: 16848684 - Increasing the relative expression of endogenous non-coding Steroid Receptor RNA Activator (SRA) in human breast cancer cells using modified oligonucleotides.
Cooper C, Guo J, Yan Y, Chooniedass-Kothari S, Hube F, Hamedani MK, Murphy LC, Myal Y, Leygue E. Cooper C, et al. Nucleic Acids Res. 2009 Jul;37(13):4518-31. doi: 10.1093/nar/gkp441. Epub 2009 May 29. Nucleic Acids Res. 2009. PMID: 19483093 Free PMC article. - Steroid receptor RNA activator (SRA1): unusual bifaceted gene products with suspected relevance to breast cancer.
Leygue E. Leygue E. Nucl Recept Signal. 2007 Aug 3;5:e006. doi: 10.1621/nrs.05006. Nucl Recept Signal. 2007. PMID: 17710122 Free PMC article. Review. - Steroid receptor RNA activator: Biologic function and role in disease.
Liu C, Wu HT, Zhu N, Shi YN, Liu Z, Ao BX, Liao DF, Zheng XL, Qin L. Liu C, et al. Clin Chim Acta. 2016 Aug 1;459:137-146. doi: 10.1016/j.cca.2016.06.004. Epub 2016 Jun 6. Clin Chim Acta. 2016. PMID: 27282881 Review.
Cited by
- Epigenetic mechanisms and the hallmarks of cancer: an intimate affair.
Darwiche N. Darwiche N. Am J Cancer Res. 2020 Jul 1;10(7):1954-1978. eCollection 2020. Am J Cancer Res. 2020. PMID: 32774995 Free PMC article. Review. - Coding or Noncoding, the Converging Concepts of RNAs.
Li J, Liu C. Li J, et al. Front Genet. 2019 May 22;10:496. doi: 10.3389/fgene.2019.00496. eCollection 2019. Front Genet. 2019. PMID: 31178900 Free PMC article. Review. - Coding and Non-coding RNAs, the Frontier Has Never Been So Blurred.
Hubé F, Francastel C. Hubé F, et al. Front Genet. 2018 Apr 18;9:140. doi: 10.3389/fgene.2018.00140. eCollection 2018. Front Genet. 2018. PMID: 29720998 Free PMC article. No abstract available. - Long noncoding RNAs in development and cancer: potential biomarkers and therapeutic targets.
Fatima R, Akhade VS, Pal D, Rao SM. Fatima R, et al. Mol Cell Ther. 2015 Jun 12;3:5. doi: 10.1186/s40591-015-0042-6. eCollection 2015. Mol Cell Ther. 2015. PMID: 26082843 Free PMC article. - From discovery to function: the expanding roles of long noncoding RNAs in physiology and disease.
Sun M, Kraus WL. Sun M, et al. Endocr Rev. 2015 Feb;36(1):25-64. doi: 10.1210/er.2014-1034. Epub 2014 Nov 26. Endocr Rev. 2015. PMID: 25426780 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases